• HOME
  • ABOUT DKP
  • DKP introduction
  • DKP History

DKP HISTORY

HISTORY

Present~2010
The Second Launch
  • 2020
    OctoberExport pharmaceuticals to NATO(North Atlantic Treaty Organization)
    SeptemberExport SILKRON Cream reached to 80 million tubes of accumulated sales (Since July 2008)
    AugustLaunched VR Tab., treatment of Hypertension and Dyslipidemia
    JulyMansik Chang was appointed as the President
    JuneMain sponsorship agreement with KIWOOM HEROS baseball team
    FebruaryLaunched Mentine Tab. for treatment of Severe Alzheimer
  • 2019
    JulyLaunched the Incrementally Modified Drugs firstly in the world, PF Cap. for treatment of Dyslipidemia
    JuneExceeded 1 million USD accumulated sales of Aragan Series to Taiwan
    MarchApproval of JAPAN PMDA GMP for sterile pharmaceutical freeze-drying product (Tathione ophthalmic solution 2%)
  • 2018
    JulyLaunched Eltine Cap. as antitussive expectorants
    JanuaryTabactam Inj. (treatment of Severe infection) exceeded annual sales of 10 billion KRW
    JanuaryLaunched Thy 1 Inj. for adjuvant treatment of Flu vaccine
  • 2017
    DecemberDongkwang exceeded annual sales of 100 billion KRW
    JuneOfficial sponsor for the 2017 FIVB volleyball world League
    JuneExport Argan Inj. for treatment of osteoarthritis to Taiwan
  • 2016
    SeptemberExceeded 1 million USD accumulated export sales to CIS countries
    AugustLaunched Esomark Tab. as Proton Pump Inhibitors, PPI
    JulyExport Argan Plus Inj. for treatment of osteoarthritis to UAE
    MayLaunched Sodium Ibandronate Inj. for treatment of osteoporosis
  • 2015
    AprilEntered the Middle East market
    AprilReleased Dongkwang Limaprost Tab, a medicine for lumbar spinal canal stenosis
    MarchReleased Dongkwang Tamsulosin HCI, a medicine for prostatic hypertrophy
    FebruaryExtended the line for freeze-drying injections: (United States) Edwards
  • 2014
    DecemberCorporate divestiture/new establishment
    DecemberExceeded annual export amount of $2 million for the first time for the single item of Silkron Cream (extensive skin disease treatment)
    AugustReleased product adding 1g of capacity for Dongkwang Meropenem Sodium Carbonate, an antibiotic
  • 2013
    DecemberWon the 50th Trade Day $5 million Export Tower
    NovemberEngaged in co-marketing activities for Streptokinase Tab., an anti-inflammatory enzyme preparation (JS Pharmaceuticals Ltd.)
    JuneEngaged in co-marketing sales of Araganplus Injection, a medicine for degenerative arthritis (Daehwa Pharm Co., Ltd.)
    MayEngaged in co-marketing for Traumeel Injection, an anti-inflammatory enzyme preparation (Sae Han Pharm Co., Ltd.)
    FebruaryExported for the first time in the former Soviet Republics
    FebruaryNewly constructed an injectable powder line for the cefa antibiotic
  • 2012
    DecemberReleased Denargra Tab, a medicine for erectile dysfunction
    AugustReleased Pantasole Injection, a peptic ulcer solvent (product producing vials for freeze-drying)
    JulyAcquired European certification (CE certificate) for "ARAGAN inj. and “ARAGAN PLUS inj."
    MayWon grand price for 2012 Customer Loved Brand held by Economist, JoongAng Ilbo with "BAEKILHUAE Sol.," a hair loss treatment agent
    MarchWon the National Tax Service Director’s Award for Excellent Taxpaying Entity, selected by the National Tax Service
  • 2011
    NovemberWon the 48th Trade Day $3million Export Tower
    OctoberNewly established a line for freeze-drying injection: (Japan) Kyowa
2009 ~ 2000
Stable development
  • 2009
    OctoberReleased XATZOSIN XL Tab, a medicine for prostatic hypertrophy
    SeptemberReleased RISET Tab., a medicine for preventing osteoporosis
    SeptemberAdditionally extended a line for ampoule-type injections (Germany) Bosch line
  • 2008
    MayReleased Araganplus Injection for treating degenerative arthritis
    AprilExtended a line for highly viscous pre-filled syringes: (Germany) Groninger charger
    JanuaryTransferred the central research center of Dongkwang Pharm (Seoul)
  • 2007
    AprilReleased Levodip Tab, an antitussive expectorants
  • 2006
    MarchReleased Famnova Tab, a medicine for shingles
  • 2005
    NovemberReleased a new product after completing the bioequivalence test of over eight products, in addition to Arendro Tab
  • 2003
    DecemberCompleted the bioequivalence test for Tinasole Capsule
    OctoberCompleted the bioequivalence test for eight products, in addition to Dongkwang Enalapril Tab
    SeptemberNewly established a line for prefilled syringes
  • 2002
    MarchAppointment of CEO You, Byeong-gil
  • 2001
    NovemberReleased Loxoprofen Tab and Lovastatin Tab, which have undergone the bioequivalence test
    JanuaryAppointment of CEO Kim, Cheon-mun
  • 2000
    OctoberAppointment of CEO Choi, Sang-rok
1999년 ~ 1990년
Dongkwang in the World
  • 1997
    FebruaryReleased Kerola Instromusular Injection/Tab (Ketorolac), a non-opioid painkiller that had undergone the bioequivalence test
  • 1995
    JulyReleased Potec Tab (Biphenyl Dimethyl Dicarboxyl ate), a liver-specializing medicine that had undergone the bioequivalence test
    JanuaryStarted to engage foreign markets and exported pharmaceuticals to Hong Kong, Myanmar, and Vietnam
  • 1994
    SeptemberReleased Dongkwang Ribostamycin Sulfate Injection, an antibiotic for the aminoglycoside system
    JanuaryAppointment of CEO Lee, Jong-ryul
  • 1993
    DecemberDesignated as a qualified entity for Outstanding Pharmaceutical Manufacturing and Management (KGMP)
    AprilEstablished the central research center and transferred Pyeongtaek Plant (KGMP)
  • 1992
    JanuaryApproved for NSAID Unimeton Tab (Nabumetone), a new prodrug-type medicine in Korea
  • 1991
    AugustChanged company name to Dongkwang Pharm Co. Ltd., from GAEYANG Co., Ltd.
    JuneReleased Dongkwang Mesalazine Tab, a medicine for Crohn’s Disease, an ulcerative colitis
    JuneStarted construction of Pyeongtaek Plant
    JanuaryChanged company direction to enter the medical market by focusing production on the pharmaceuticals for hospitals, such as injections, anti-inflammatory analgesic drugs, and antibiotics
1989년 ~ 1980년
Takeoff and Achievements
  • 1989
    JuneReleased Oymol Injection (methocarbamol), a skeletal muscle relaxant
    JuneReleased Ribotase Tab with triple effect of digestion, stomach strengthening, and de-acidification
    JanuaryReleased Pantase-A Tab, a complete digestive enzyme
    JanuaryAppointment of CEO Kim, Ok-ju
  • 1981
    JuneAcquired by GAEYANG Co., Ltd., CEO Woo, Jong-hun
1979년 ~ 1970년
A Company Recognized of its Value
  • 1978
    AugustAcquired by Daeyungak Co., Ltd., CEO Han, Hea-seok, and changed company name to Dongkwang Pharm Co., Ltd.
  • 1977
    MayTransferred plant (Guro-gu, Garibong-dong)
  • 1976
    FebruaryWon Export Contribution Award by exporting SAMBORYEOK, a ginseng drink, and a soft capsule of ginseng extract, to areas such as Hong Kong and Taiwan (Minister of Commerce and Industry)
    1975
    SeptemberReleased Triamcinolone Injection, an adrenocortical hormone drug
    JanuaryApproved and registered for the trade business
    1971
    FebruaryReleased digestive medicines Pantase Gastrointestinal Agent and Pantase Oral Solution
    1970
    AprilWon the Prime Minister’s Award for contributing to the improvement of public health on World Health Day
    FebruaryReleased Dongkwang Codenong Tab, an antitussive expectorant
1969년 ~ 1950년
Beginning of Dongkwang
  • 1969
    FebruaryReleased Novaquing Syrup, a comprehensive flu medicine
  • 1968
    JuneReleased Tricort Cream, a remedial agent for skin disease
  • 1963
    MarchReleased Pantase Tab, a complete digestive enzyme
  • 1962
    AugustTransferred the research center of Dongkwang Pharm. to Seoul
  • 1956
    AugustEstablished the research center of Dongkwang Pharm. (Busan)
  • 1952
    SeptemberEstablished Dongkwang Pharm. (approved to manufacture pharmaceuticals), CEO Lee, Gyu-young